Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05410353 · ClinicalTrials.gov registry record · NA
Choosing Healthy Activities and Lifestyle Management Through Portal Support
A NA study of Weight Loss and Overweight and Obesity, sponsored by University of Tennessee.
- Active
- Registry status
- NA
- Development phase
- 229
- Enrollment target
- 1
- Study location
NCT05410353: Active NA study of Weight Loss and Overweight and Obesity, sponsored by University of Tennessee.
NCT05410353 is a NA study of Weight Loss and Overweight and Obesity that is active but no longer recruiting, run by University of Tennessee. The registered enrollment target is 229 participants, below the 1,499-participant average among 116 other Weight Loss trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05410353, a NA study of Weight Loss and Overweight and Obesity, is active but no longer recruiting, sponsored by University of Tennessee.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to randomize 250 participants to 1 of 2 arms: a.) an Active Intervention Group (based on the Look AHEAD\* ILI) or b.) a Comparison Group (based on the Look AHEAD DSE Comparison group) to test the hypothesis that a multicomponent, multilevel behavioral weight loss intervention (Active Intervention Group) adapted for different population groups and delivered through Health Information Technology (Health IT) tools via the Electronic Health Record (EHR) patient portal, will result in significantly greater weight loss 12 months after enrollment compared to the Comparison Group. \*The Look AHEAD study was a multi-center, randomized clinical trial involving overweight and obese persons with type 2 diabetes, aimed to determine the effects on the cardiovascular outcomes of an intensive lifestyle intervention (ILI) for weight loss, in comparison to the diabetes support and education intervention (DSE).
Primary Outcome
This is calculated for each follow-up visit as ((weight at FU visit - baseline weight) / (baseline weight)) × 100%.
Conditions Studied
Interventions
- BEHAVIORAL Comparison Group
- BEHAVIORAL Active Intervention Group
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center / Department of Preventive Medicine - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05410353 still lists
NCT05410353 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 1,499-participant average among 116 other Weight Loss trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Comparison Group is the first listed.
NCT05410353 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05410353 about?
NCT05410353 is a clinical study titled "Choosing Healthy Activities and Lifestyle Management Through Portal Support". The study aims to randomize 250 participants to 1 of 2 arms: a.) an Active Intervention Group (based on the Look AHEAD\* ILI) or b.) a Comparison Group (based on the Look AHEAD DSE Comparison group) to test the hypothesis that a multicomponent, multilevel behavioral weight loss intervention (Active ...
What is the current status of trial NCT05410353?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 229 participants. The study started on 2023-02-24. Estimated completion is 2026-12-31.
What conditions does trial NCT05410353 study?
This clinical trial studies the following conditions: Weight Loss, Overweight and Obesity, Behavior, Health.
What interventions are being tested in trial NCT05410353?
The interventions under investigation include: Comparison Group (BEHAVIORAL), Active Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05410353?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05410353 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05410353's enrollment target sits among peer trials
229 25th of 116 higher than 92 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI